Clinical Trial Update: Treatment of Zollinger-Ellison Syndrome With Prevacid [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating lansoprazole (Prevacid) for Zollinger-Ellison syndrome; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Endocrine Neoplasia
• Zollinger-ellison Syndrome

Drugs mentioned

• PREVACID (LANSOPRAZOLE)

Snippet

Sponsor: Charles Mel Wilcox, MD | Conditions: Zollinger-Ellison Syndrome, Multiple Endocrine Neoplasia | Phase 4 | Status: COMPLETED | Results posted: 2012-10-19